With or without FUS, it is the anatomy that dictates the dementia phenotype
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Not so long ago, Alois Alzheimer's dominance over Arnold Pick appeared total and irreversible. Alzheimer's disease was placed at the helm of a global pandemic whilst Pick's disease was declared a rare curiosity and other non-Alzheimer dementias faced the embarrassment of lacking distinctive histopathology. How rapidly things change! We now know that the family of frontotemporal lobar degenerations (FTLDs), which includes Pick's disease, is arguably the most important cause of pre-senescent dementia; that its hereditary forms can be transmitted through mutations in the tau or progranulin ( PGRN ) genes; and that the abnormal protein accumulations include hyperphosphorylated tau and the TAR DNA binding protein TDP-43 (Arai et al. , 2006; Bigio, 2008; Boeve and Hutton, 2008; Josephs, 2008; Neumann et al. , 2006). Despite this relatively rapid progress over the past 15 years, there still remain FTLD cases either having non-specific ubiquitin deposits or lacking distinctive inclusions. One of these lingering pockets of resistance now appears to have yielded to the work of Mackenzie and colleagues (Mackenzie et al. , 2009). In this issue of Brain , these investigators report that 100% of their FTLD cases with heretofore uncharacterized ubiquitin inclusions harbour abnormal accumulations of the ‘fused in sarcoma’ (FUS) product, a protein also recently linked to amyotrophic lateral sclerosis (Kwiatkowski et al. , 2009; Vance et al. , 2009). The addition of FUS to the FTLD landscape gives neuropathologists and geneticists additional cause for celebration. But what about clinicians who see patients rather than stained brain slices? Can they use this new knowledge to infer the nature of the pathology at the bedside? Conversely, is there a straight path from molecular pathology to cognition, so that a disease-specific blood or cerebrospinal fluid biomarker may in time prove as informative for clinical deficits as …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
The evolution and pathology of frontotemporal dementia
Kertesz, A., McMonagle, P., Blair, M., Davidson, W., & Munoz, D. G. (2005) · Brain · doi:10.1093/brain/awh598 · Cited by 609
Clinicopathological correlates in frontotemporal dementia
Hodges, J. R., Davies, R. R., Xuereb, J. H., Casey, B., Broe, M., Bak, T. H., Kril, J. J., & Halliday, G. M. (2004) · Annals of Neurology · doi:10.1002/ana.20203 · Cited by 580
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia
Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Léger, G. C., Rademaker, A., Weintraub, S., & Bigio, E. H. (2008) · Annals of Neurology · doi:10.1002/ana.21388 · Cited by 513
Self-citationFrontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia
Seeley, W. W., Crawford, R., Rascovsky, K., Kramer, J. H., Weiner, M., Miller, B. L., & Gorno-Tempini, M. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.38 · Cited by 506
Frontotemporal Dementia and Corticobasal Degeneration in a Family with a P301S Mutation in Tau
Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., Morbin, M., Primavera, A., Carella, F., Solaro, C., et al. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00011 · Cited by 450
The clinical profile of right temporal lobe atrophy
Chan, D., Anderson, V., Pijnenburg, Y., Whitwell, J., Barnes, J., Scahill, R., Stevens, J. M., Barkhof, F., Scheltens, P., Rossor, M. N., et al. (2009) · Brain · doi:10.1093/brain/awp037 · Cited by 377
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia
Liu, W., Miller, B. L., Kramer, J. H., Rankin, K., Wyss-Coray, C., Gearhart, R., Phengrasamy, L., Weiner, M., & Rosen, H. J. (2004) · Neurology · doi:10.1212/01.wnl.0000113729.77161.c9 · Cited by 313
Cited by
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza-Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 707
The Neuropsychological Profile of Alzheimer Disease
Weintraub, S., Wicklund, A. H., & Salmon, D. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006171 · Cited by 569
Self-citationPrimary progressive aphasia and the evolving neurology of the language network
Mesulam, M.-M., Rogalski, E. J., Wieneke, C., Hurley, R. S., Geula, C., Bigio, E. H., Thompson, C. K., & Weintraub, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.159 · Cited by 394
Self-citationClinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. E., Mead, S., Isaacs, A. M., Beck, J., Hardy, J., de Silva, R., Warrington, E., et al. (2011) · Brain · doi:10.1093/brain/awr198 · Cited by 359
Mesulam, M.-M., Weintraub, S., Rogalski, E. J., Wieneke, C., Geula, C., & Bigio, E. H. (2014) · Brain · doi:10.1093/brain/awu024 · Cited by 334
Self-citationWolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001412107 · Cited by 248
Self-citationKim, E.-J., Sidhu, M., Gaus, S. E., Huang, E. J., Hof, P. R., Miller, B. L., DeArmond, S. J., & Seeley, W. W. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr004 · Cited by 204
“based on the principle that the anatomical pattern, rather than the underlying molecular pathology, drives the clinical syndrome (Weintraub and Mesulam 2009).”
BackgroundInfluentialNeuropathology of frontotemporal lobar degeneration: A review
Bahia, V. S., Takada, L. T., & Deramecourt, V. (2013) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642013dn70100004 · Cited by 48
Kawles, A., Nishihira, Y., Feldman, A., Gill, N., Minogue, G., Keszycki, R., Coventry, C., Spencer, C., Lilek, J., Ajroud, K., et al. (2022) · Brain · doi:10.1093/brain/awab368 · Cited by 34
Self-citation
Metadata
- Authors
- Weintraub, S., & Mesulam, M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-27
- Volume
- 132
- Issue
- 11
- Pages
- 2906-2908
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1983295944
- Cited by
- 45
- References
- 11
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.